Objectives: To study the correlation between the HLA-B*5701 allele and the single nucleotide polymorphism in HCP5 (rs2395029). Patients and methods: All HIV patients naive for abacavir seen at our institution between September 2007 and December 2008 were prospectively screened for HLA-B*5701. HCP5 rs2395029 genotyping was carried out by allelic discrimination using the TaqMan 5′-nuclease assay. High-resolution HLA class I typing was undertaken using sequence-specific primers. Results: A total of 245 HIV patients were included in the study. A good correlation between HLA-B*5701 and HCP5 was observed (negative and positive predictive values of 100% and 93%, respectively). Conclusions: The use of HCP5 rs2395029 testing could be as useful as HLA-B*5701 typing to prevent the abacavir hypersensitivity reaction. Given that HCP5 testing is cheaper, less time-consuming and easier to perform than HLA typing, it may confidently replace the latter in clinical settings. © The Author 2010.
CITATION STYLE
Rodríguez-Nóvoa, S., Cuenca, L., Morello, J., Córdoba, M., Blanco, F., Jiménez-Nácher, I., & Soriano, V. (2010). Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701. Journal of Antimicrobial Chemotherapy, 65(8), 1567–1569. https://doi.org/10.1093/jac/dkq204
Mendeley helps you to discover research relevant for your work.